COMMUNIQUÉS West-GlobeNewswire

-
Merus Announces Financial Results for the Third Quarter 2018 and Provides Business Update
27/12/2018 -
Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
27/12/2018 -
iCAD Announces CFO Transition
27/12/2018 -
Tauriga Sciences Inc. Selects Name & Logo Under Which it will Brand its Cannabis Infused Chewing Gum Product Line
27/12/2018 -
Golden Leaf Holdings Ltd. Hires New CEO/President
27/12/2018 -
Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model
27/12/2018 -
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
27/12/2018 -
Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets
27/12/2018 -
Digital Mental Health Startup headversity Launches Workplace Resilience Program
27/12/2018 -
Ossur Hf : Transactions in relation to share buyback program
27/12/2018 -
Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook
27/12/2018 -
VistaGen Therapeutics to Present at 11th Annual Biotech Showcase
27/12/2018 -
PSIQ Expects Strong Revenue Growth in 2019 as President Trump Signs Farm Bill Legalizing Hemp CBD Nationwide
27/12/2018 -
ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference
27/12/2018 -
Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy
27/12/2018 -
MannKind Corporation to Hold Investor Conference Call
27/12/2018 -
IBEX Grants Stock Options
27/12/2018 -
NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel
27/12/2018 -
BrainStorm Issues 2018 Letter to Shareholders
27/12/2018
Pages